Global Attention Deficit Hyperactivity Disorder (ADHD) Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
Attention Deficit Hyperactivity Disorder (ADHD) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Attention Deficit Hyperactivity Disorder (ADHD) market is projected to reach US$ 19380 million in 2034, increasing from US$ 12240 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
There are two main types of drugs used to treat ADHDstimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.
ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Attention Deficit Hyperactivity Disorder (ADHD) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Distribution Channel and Regions Listed in the Report
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Attention Deficit Hyperactivity Disorder (ADHD) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Distribution Channel and Revenue analysis of Each Distribution Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Attention Deficit Hyperactivity Disorder (ADHD) introduction, etc. Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Attention Deficit Hyperactivity Disorder (ADHD) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Attention Deficit Hyperactivity Disorder (ADHD) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Attention Deficit Hyperactivity Disorder (ADHD) market is projected to reach US$ 19380 million in 2034, increasing from US$ 12240 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2034. Demand from Hospital Pharmacy and Retail Pharmacy are the major drivers for the industry.
There are two main types of drugs used to treat ADHDstimulants and non-stimulants
The main manufacturers of stimulants are in Europe and America, and the main manufacturers of non-stimulants are in China.
ADHD is mainly used in hospital pharmacies and retail pharmacies. Among them, in 2020, the market share of retail pharmacies accounted for approximately 83%
Takeda has the highest market share in ADHD by major global companies, which is much higher than the market share of other companies, about 21% in 2020.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Attention Deficit Hyperactivity Disorder (ADHD) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Distribution Channel and Regions Listed in the Report
By Company
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
CTFH
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Attention Deficit Hyperactivity Disorder (ADHD) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Distribution Channel and Revenue analysis of Each Distribution Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Attention Deficit Hyperactivity Disorder (ADHD) introduction, etc. Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Attention Deficit Hyperactivity Disorder (ADHD) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices